Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
14%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
CANC
56
HOLDINGS
24%
ALSO IN SBIO
SBIO
87
HOLDINGS
16%
ALSO IN CANC
SECTOR DRIFT (CANC minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
CG ONCOLOGY, INC. | 2.7% | 3.3% | 2.7% |
|
RELAY THERAPEUTICS, INC. | 1.7% | 2.2% | 1.7% |
|
IDEAYA BIOSCIENCES, INC. | 2.5% | 1.7% | 1.7% |
|
IMMUNOME, INC. | 2.7% | 1.4% | 1.4% |
|
NUVATION BIO INC CLASS A | 1.3% | 1.2% | 1.2% |
CANC Overweight Relative to SBIO
|
REVOLUTION MEDICINES, INC. | 6.1% |
|
ELI LILLY & CO | 5.3% |
|
COGENT BIOSCIENCES INC | 5.0% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.5% |
|
NOVARTIS AG | 4.0% |
|
ABBVIE INC | 3.8% |
|
MERCK & CO. INC. | 3.6% |
|
BRISTOL-MYERS SQUIBB CO | 3.5% |
|
JOHNSON & JOHNSON | 3.4% |
|
EXELIXIS INC | 2.8% |
CANC Underweight Relative to SBIO
|
CRINETICS PHARMACEUTICALS INC | -4.7% |
|
APOGEE THERAPEUTICS, INC. | -4.5% |
|
DIANTHUS THERAPEUTICS INC | -3.0% |
|
ORUKA THERAPEUTICS INC | -3.0% |
|
TRAVERE THERAPEUTICS, INC. | -2.9% |
|
DEFINIUM THERAPEUTICS INC | -2.5% |
|
EDGEWISE THERAPEUTICS, INC. | -2.4% |
|
ACADIA PHARMACEUTICALS INC | -2.3% |
|
DYNE THERAPEUTICS INC | -2.2% |
|
DENALI THERAPEUTICS INC. | -2.0% |